CID 156440741

Adrixetinib

Structural Information

Molecular Formula
C25H24F3N5O5
SMILES
CCCN1C=C(C(=N1)C(=O)NC2=NC=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)OCC(F)(F)F
InChI
InChI=1S/C25H24F3N5O5/c1-4-9-33-13-21(37-14-25(26,27)28)23(32-33)24(34)31-22-6-5-15(12-30-22)38-18-7-8-29-17-11-20(36-3)19(35-2)10-16(17)18/h5-8,10-13H,4,9,14H2,1-3H3,(H,30,31,34)
InChIKey
BWUUJXXFCSYLFW-UHFFFAOYSA-N
Compound name
N-[5-(6,7-dimethoxyquinolin-4-yl)oxypyridin-2-yl]-1-propyl-4-(2,2,2-trifluoroethoxy)pyrazole-3-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

2
Patents

531.173 Da
Monoisotopic Mass

4.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 532.18028 225.9
[M+Na]+ 554.16222 234.4
[M-H]- 530.16572 228.8
[M+NH4]+ 549.20682 228.2
[M+K]+ 570.13616 228.8
[M+H-H2O]+ 514.17026 210.8
[M+HCOO]- 576.17120 239.9
[M+CH3COO]- 590.18685 247.8
[M+Na-2H]- 552.14767 226.8
[M]+ 531.17245 232.1
[M]- 531.17355 232.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe